%D8%A3%D8%B3%D9%8A%D8%AA%D8%A7%D8%AA_%D8%A7%D9%84%D8%BA%D9%84%D8%A7%D8%AA%D9%8A%D8%B1%D8%A7%D9%85%D8%B1Acetat_de_glatiramerGlatiramer-acet%C3%A1tGlatirameracetatGlatiramer_acetateAcetato_de_glatiramer%DA%AF%D9%84%D8%A7%D8%AA%DB%8C%D8%B1%D8%A7%D9%85%D8%B1_%D8%A7%D8%B3%D8%AA%D8%A7%D8%AA%D7%92%D7%9C%D7%98%D7%99%D7%A8%D7%9E%D7%A8_%D7%90%D7%A6%D7%98%D7%98Glatiramer_acetato%E3%82%B0%E3%83%A9%E3%83%81%E3%83%A9%E3%83%9E%E3%83%BCGlatirameerOctan_glatirameruAcetato_de_glatir%C3%A2mero%D0%93%D0%BB%D0%B0%D1%82%D0%B8%D1%80%D0%B0%D0%BC%D0%B5%D1%80%D0%B0_%D0%B0%D1%86%D0%B5%D1%82%D0%B0%D1%82Glatiramer_acetatGlatiramer_acetatGlatiramer_acetatGlatiramer%D0%93%D0%BB%D0%B0%D1%82%D0%B8%D1%80%D0%B0%D0%BC%D0%B5%D1%80%D1%83_%D0%B0%D1%86%D0%B5%D1%82%D0%B0%D1%82Glatiramer_acetateQ418274
about
P3781
Comparison of Bone Effects With Copaxone and Interferon in Multiple SclerosisEfficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple SclerosisA Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple SclerosisNeuroprotection and Repair in Optic NeuritisTreatment Interruption of NatalizumabA Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to PlaceboGlatiramer Acetate for Multiple Sclerosis With Autoimmune ComorbiditiesDiclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer AcetateImmune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting CellsEfficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMSEfficacy and Safety of GTR in Comparison to Copaxone®Tysabri Observational Cohort Study - Multiple Sclerosis (MS) RegistriesPhase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple SclerosisComparison of Clinical Effects of Rituximab and Glatiramer Acetate in Primary Progressive Multiple Sclerosis PatientsDiscontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).
P4844
OP23 – 2759: Pharmacological treatment of Rett syndrome with glatiramer acetate (Copaxone)Interferon β-1b and glatiramer acetate effects on permanent black hole evolutionFive-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France
P921
Q61918013-B32225A9-8A08-49D0-818D-B135BC4A6662Q61920958-457A44AA-9599-4651-A2A9-91A2B6860D5CQ61920981-99E2ADB2-972B-45E4-9F81-B1446F5DAD6EQ61921187-04E0DF77-2E3C-4DAC-8676-44C6AACEAC4EQ61938418-63F42578-9E06-4BDA-9D4F-554A30A6B713Q61938726-D8C84A39-2564-4CA3-A8F3-AF5B515D6006Q61939132-586A087B-309C-4FA9-88CB-09DA8F2B22ABQ61966059-DD732C97-00AE-4C9C-87F9-DC34144FF9D7Q61966330-FA6A0C95-F04D-4F80-AFA4-D2AA71787669Q61969894-23CA1F59-B8BB-4A1B-8649-7680455DC740Q61975909-295BDAB8-B75B-430A-89A5-5911ADEDF40CQ62814572-48683FC5-DFD6-4D08-9826-0C1F38AAB56FQ63321114-32AC99F5-21D5-444A-9547-232ADC1DEFE3Q63402232-D3C3DB4C-8D5B-4A52-A291-00BBC0FD717DQ63402607-311CE8CB-F8B4-4C41-8027-C181BA05BB60Q63572521-BF6DF07E-322B-4A76-B1BD-EC3450EFAB79Q86263927-0942CF96-19C4-4CD1-A6DF-F3978929AF4B
P4844
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
component quimic
@oc
compositum chemicum
@la
name
Acetato de glatiramer
@es
Glatiramer acetat
@sh
Glatiramer acetat
@sl
Glatiramer acetat
@sr
Glatiramer acetat
@sr-el
Glatiramer acetate
@vi
Glatiramer acetato
@it
Glatiramer
@sv
Glatirameracetat
@de
Octan glatirameru
@pl
type
label
Acetato de glatiramer
@es
Glatiramer acetat
@sh
Glatiramer acetat
@sl
Glatiramer acetat
@sr
Glatiramer acetat
@sr-el
Glatiramer acetate
@vi
Glatiramer acetato
@it
Glatiramer
@sv
Glatirameracetat
@de
Octan glatirameru
@pl
altLabel
C25H45N5O
@sr
C25H45N5O1
@sr
COP-1
@en
Copaxon
@sr
Copaxone
@cs
Copaxone
@de
Copaxone
@en
Copaxone
@nl
Copaxone
@pl
Copaxone
@ru
prefLabel
Acetato de glatiramer
@es
Glatiramer acetat
@sh
Glatiramer acetat
@sl
Glatiramer acetat
@sr
Glatiramer acetat
@sr-el
Glatiramer acetate
@vi
Glatiramer acetato
@it
Glatiramer
@sv
Glatirameracetat
@de
Octan glatirameru
@pl
P2868
P31
P486
P592
P6366
P646
P662
P2017
C[C@@H](C(=O)O)N.CC(=O)O.C1=CC ...... )O)N.C(CC(=O)O)[C@@H](C(=O)O)N
P2067
623.301387
P2115
N0000148459
P2167
P2275
Glatiramer acetate
@en
P231
147245-92-9